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Up until the 1960s and 1970s, diarrhea, malabsorption syndrome, and failure to thrive
were the presenting symptoms and signs of celiac disease (CD) in young infants; however
this disease was also at the same time reported to be disappearing. Indeed, clinical
childhood CD was seen to transform into a milder form, resulting in an upward shift in
age at diagnosis during the 1970s (and years later for many countries). This changing
pattern of CD presentation then altered the epidemiology of the disease, with major
differences between and within countries observed. An awareness of the changing
clinical nature of CD and use of case-finding tools to detect even clinically silent CD
became an important factor in this changing epidemiology. Countries report both low and
high prevalence but it seems to be on the increase resulting in a population-based level
of 1–2%. This paper discusses the potential causes and environmental factors behind
these observed clinical changes, identifying new clues from different studies published
at the time this transformation took place. For instance, it was found that breastfeeding
postponed the diagnosis of the disease but did not altogether prevent it. Moreover,
gluten introduction at a young age, specifically at the mean age of 2 months, seemed
to also have a clear impact in inducing malabsorption syndrome and failure to thrive in
young infants in addition to other factors such as gluten intake volume and type of cereal
present in the weaning food. Further, the impact of cow’s milk and its high osmolarity
might have played an important role; humanized milk formulas were not yet invented.
Future epidemiological studies on the contributing environmental factors to the shift in
CD presentation are thus recommended for countries in which these changing clinical
features are still being observed.
Keywords: celiac disease, changing pattern, incidence, prevalence, infant feeding, autoimmunity, awareness,
screening
INTRODUCTION
Celiac disease (CD) has earlier been considered to be a rare intestinal disease occurring only in
children, a disease that Samuel Gee in 1888 presented as the “coeliac affection” (1). As summarized
by John Walker-Smith, Gee was very accurate in his description of childhood CD: “it is a kind
of chronic indigestion, which is especially apt to affect children between 1 and 5 years old and
where signs of the disease are yielded by the feces, being loose, but not watery, bulky, and pale.
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The onset of the disease is usually gradual and cachexia is a
constant symptom. The belly is mostly soft and often distended”
(2). The conception on CD changed in early 1950s by the
discoveries of Dicke, who showed that the cause of harm in
patients with CD was dietary gluten; in fact, he specifically
noted that the disease was not caused by all cereals but,
specifically, wheat flour (3). The next major research discovery
occurred in the 1950s and involved the use of a peroral
intestinal suction biopsy apparatus as a diagnostic tool. When
gluten was ingested by children with CD, the development of
a characteristic mucosal lesion in the jejunum was observed,
namely villous atrophy with crypt hyperplasia (4). Moreover,
new biopsy criteria were adopted early on in Europe by the
European Society for Pediatric Gastroenterology, even for young
infants (4–6).
Celiac disease (CD) was long thought to be a rare disease,
occurring only in children with a classical presentation known
as malabsorption syndrome and failure to thrive (7). However,
today, CD is known as an autoimmune systemic disorder
occurring in genetically susceptible individuals and perpetuated
by the daily ingestion of gluten cereals (i.e., wheat, rye, and
barley) with manifestations both in the small intestine and
in extraintestinal organs (7–10). CD is more complex than
simple intestinal malabsorption, which is, in fact, no longer
essential for diagnosis. Another important milestone in CD
diagnostics and screening was the discovery and clinical use
of highly CD-pathognomonic, circulating, gluten-dependent
tissue autoantibodies measured within the immunoglobulin A
(IgA) class (11–18). Awareness of the disease and use of these
tools have come to determine the epidemiological outcome
in CD research. Furthermore, late-developing, small-intestinal
mucosal injury also plays a role in the changing pattern and
epidemiology of CD. In other words, this refers to a CD
latency in which the disease exists but is not manifested at
the mucosal level, even if the patient has ingested gluten
for decades (9). Susceptibility to CD is inherited; however,
upon a child’s first encounter with gluten he may or may
not develop the disease at a small-intestinal mucosal level
soon thereafter. Oral tolerance toward gluten can persist for
a long period of time with the deterioration of the mucosa
possibly taking place at a later age. This also explains the late
mucosal relapses during gluten challenges and late appearing
mucosal injury concordance in monozygotic twins as well
as possibly spontaneous mucosal recoveries upon continued
gluten ingestion.
Celiac disease (CD), known as a rare malabsorption
syndrome in young Caucasian children has, since the 1970s,
come to be known as a common, chronic, food-induced
autoimmune systemic disorder world-wide, diagnosed in
children, adolescents, adults, and the elderly. The changes in
perception of CD as a clinical disease and observed changes in
occurrence have been remarkable during the past 50 years. In
these aspects, there are, however, several differences between
countries and continents. This review thus discusses the pattern
of change in childhood CD presentation, its influence on
its epidemiology, increasing incidence rates, and the causes
behind them.
FIGURE 1 | Changing pattern of childhood celiac disease affecting
epidemiology results in Finland in 1960–1984. Decreasing numbers of cases
were diagnosed in infancy and increasing numbers diagnosed at school age
and adolescence after 1972. [Reproduced with permission from Mäki
et al. (23)].
CHANGING CLINICAL FEATURES
In the 1960s, a child with CD typically presented with prolonged
diarrhea, malabsorption syndrome, and failure to thrive, often
before the age of 2 (7). However, a shift in CD presentation
became evident during the 1970s and 1980s, with childhood CD
reportedly disappearing altogether (19–22). In Finland, however,
from 1970 onward, it was observed that, in addition to the
disappearance of the classical form of CD in young children,
the incidence rates of the milder forms of the disease increased,
resulting in an upward shift in age at diagnosis from 2 to 8 years
(Figure 1) (23). This was also evident in the UK, with a changing
disease pattern seeming to be a fact; childhood CD tended to
present at later age (24).
When CD manifests during the later stages of childhood,
symptoms can be gastrointestinal; however the disease is
often monosymptomatic, presenting with short stature, delayed
puberty, and joint pain or anemia due to isolated iron deficiency
(23, 25–30). Gastrointestinal symptoms may also be mild or
non-existent. If the healthcare professionals are diagnosing
only classical CD presenting at young age and older children
with gastrointestinal symptoms, only the tip of the iceberg
of all CD patients are detected (Figure 2), epidemiologically
resulting in low incidence and prevalence numbers. These
clinically silent patients, i.e., children with no symptoms or signs
suggesting CD, also exhibit a gluten-triggered and -dependent
small intestinal mucosal lesion manifestation (Figure 2). They
require an increased awareness of healthcare professionals
and a case-finding strategy for early diagnosis. Specifically,
celiac autoantibody testing can determine an underlying gluten-
induced disease, yielding high sensitivity and specificity (11–
18). The existence of clinically silent patients became evident
when performing gluten challenges to earlier diagnosed well-
treated patients (31, 32) in addition to CD screening for certain
risk groups, such as those with type 1 diabetes (13, 18) or
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FIGURE 2 | The celiac disease (CD) iceberg and the spectrum of celiac trait:
Awareness of different clinical forms of CD and clinicians’ activity in
case-finding by screening will influence the outcome of incidence rates and
prevalence in different countries and within countries.
healthy, first-degree family members (33, 34). Case-finding
using celiac-pathognomonic serum IgA class R1-type reticulin
autoantibodies (11, 12), later known as endomysial and tissue
transglutaminase antibodies (14, 15), detected the clinically silent
patients and helped change the perception of childhood CD. The
changing pattern of CD epidemiology would partly go unnoticed,
if healthcare professionals are not aware of the existence of
clinically silent CD and use a case-finding strategy in diagnostics.
Latent CD refers to the fact that the disease exists but does not
manifest at the mucosal level until at some later age. The small
intestine mucosa can stay intact upon years and decades of full
gluten ingestion, or the mucosal damage can develop gradually.
Final deterioration of the mucosa occurs when oral tolerance
toward gluten ceases (9, 35) (Figure 2). We have extensively
discussed latent and developing CD in a recent review article (9).
Latent CD patients may be serum autoantibody positive, have
a normal small intestine mucosa and thus according to biopsy
criteria be excluded for CD. These patients may even become
serum autoantibody negative upon normal gluten ingestion but
still develop the disease at some later age (36). Stenhammar et al.
addressed the latency issue in CD family studies spanning 20
years (37, 38). When a small intestine biopsy was performed for
100 first-degree relatives of index patients with childhood CD in
1982, only 2% were found to have clinically silent CD. When
they reinvestigated all first-degree relatives of the same index
patients 20–25 years later, eight new cases of CD were detected
(8.3%), two of whom were found not to have the disease in the
first study. Eleven more relatives exhibiting mild enteropathy
were identified in the new screening, and it was suggested that
they were followed carefully for potential development to overt
disease. CD incidence and prevalence figures are influenced by
the age of the patients at time of study and also whether a
changing pattern of childhood CD has taken place in the country
or setting where the study was performed.
A large European study involving 38 centers and 5,871
children with diagnosed CD confirmed that there had been
an overall mean increase in age at diagnosis from 2 years in
1975 to 4 years in 1990 (39), with Sweden being the exception
(40). The changing CD pattern has been described as occurring
at different times within and without different countries. In
the Naples region of Italy, for example, no change in age at
diagnosis was observed between 1973 and 1986 (41). In some
other parts of Italy, however, an increase in age was observed
(39), with classical forms of CD decreasing in the late 1990s and
early 2000s and silent forms significantly increasing, resulting
in an increased age at diagnosis as well (42). Similarly, no
changes in the overall clinical makeup of CD could be found in
the Netherlands between 1975 and 1994 (43) but an increased
awareness and recognition of childhood CD did ultimately
change the clinical presentation during the years 1993–2000 (44).
In the UK, considerable changes were reported mostly due to
targeted serum antibody screening. A decrease in the proportion
of patients presenting with gastrointestinal manifestations and
a rise in the number of patients without symptoms was also
observed (45). This change was still occurring in the UK during
the years 2005–2011, with over 50% of children diagnosed with
CD exhibiting few or no symptoms (46). This same type of
changing clinical pattern has been observed in Greece (47), North
America (48–50), India (51, 52), Estonia (53), Turkey (54), and
Sweden (although, in this case, only after mid-1990s when the
Swedish epidemic occurring in young infant from 1985 to 1995
had ended) (40, 55). In Finland, between 1975 and 1990, large
differences in CD incidence rates were found when comparing
Helsinki to Tampere (39), since an awareness of clinically silent
CD was not acknowledged by primary health care professionals
in the capital of Finland. Later, however, in Helsinki, the number
of patients with CD was found to increase six-fold between
2000 and 2005, with mean age at diagnosis increasing to 7.2
years (56). When comparing the two neighboring countries of
Finland and Sweden based on CD’s clinical features from 1985 to
1989, the differences found were remarkable: in Sweden, classical
clinical symptoms and a diagnosis before the age of two was
most commonly observed, whereas, in Finland, symptoms varied
much more greatly, and diagnosis was often made after the age
of 8 (57). However, the presentation of CD in Finnish children
seems to no longer be shifting, with a plateau having been reached
in recent years (58).
These observed changes in clinical presentation had inevitable
effects on the epidemiological outcomes of CD and were, in terms
of timeframe and magnitude, not similar between and among the
different countries. It is thus difficult to compare different CD
incidences from different publications and countries. Overall, a
change in the pattern of symptom presentation for childhood
CD that is in line with early observations has been noted in the
textbooks as well as in CD guidelines worldwide (7, 59–61).
In Finland, during the 1970s, there was a growing awareness
of the aforementioned changing CD pattern, as shown in
Figure 1, which influenced health care professionals’ case-finding
via screening. In fact, this awareness seemed to be the major
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factor involved in the changing epidemiology and increasing
incident rate observed in older children. However, it should
be noticed that changing epidemiology is also a result of
whether disease-specific autoantibody tools are used for case-
finding in the primary healthcare field instead of only in
secondary or tertiary referral centers. Today, children with CD
are not often so symptomatic that they would need to be
admitted to pediatric gastroenterology centers. Furthermore,
case-finding using autoantibody screening and a high index of
disease suspicion is in our experience a prominent diagnosis
method in primary care. Finland also experienced a decrease
in the yearly incidence rate during the economic crisis of the
early 1990s, during which the city of Tampere health authority
forbade primary care doctors to use reticulin or endomysial
autoantibodies as case-finding tools, suggesting instead the
cheaper but outdated crude gliadin serum antibody test. The
authority intervention resulted within a 2-year timeframe
in a three-time decrease of biopsy-verified diagnoses at the
referral center.
The current major question in pediatrics asks what has caused
the described change in the clinical presentation of CD over time.
When addressing the changing epidemiology of childhood CD
in 1992 (39), we suggested the following environmental factors
to play a role: genetic background of the population, infantile
gastroenteritis/other infections, unmodified/adapted cow’s milk
formulas, breastfeeding, age at gluten introduction, quantity of
gluten, quality of cereals, and quality of wheat gluten (62).
These environmental factors will be discussed here in more
detail. The present review is not extended to include human
leukocyte antigens (HLA), non-HLA genes, or other genetic
aspects in populations with low prevalence rates of CD, such as
those comprised of black Africans or Japanese individuals, but
did include environmental factors in populations with similar
HLA DQ2 and DQ8 background. Environmental factors have
an evident impact on intestinal epithelial cells, either through
direct interaction or through microbiota. This review does not
address any potential epigenetic mechanisms, such as histone
modifications, DNAmethylation, ormicrobial RNAmethylation,
as indicators of the changing pattern in CD epidemiology
over time.
ENVIONMENTAL FACTORS BEHIND




As early as 1953, Andersen and di Sant’Agnese found that
breastfeeding for a duration of more than 2 months delayed
the onset of diarrhea in patients with CD (63). Moreover, two
case-control studies performed in Italy indicated breastfeeding
protected patients against CD (64, 65). When evaluating whether
the duration of breastfeeding influenced age at diagnosis, a mean
increase in breastfeeding from 2.5 months in children born from
1961 to 1965 to 3.9 months in children born from 1976 to 1980
was observed. Furthermore, a significant correlation was found
between age at diagnosis and duration of breastfeeding in a study
of 45 children diagnosed with CD before the age of 6 years, with
breastfeeding found to delay the onset of symptoms (23). Thus,
prolonged breastfeeding seemed to prevent the development of
CD but did not protect patients against the disease, since it
manifest at a later age. Overall, the median age at diagnosis
was 8.8 years in Tampere, Finland during the early 1980s (39).
In the neighboring country of Sweden, at the time of their CD
epidemic in 1985–1995 (described below) and a national trend in
short breastfeeding duration (40), the median age at childhood
diagnosis was 1.3 years (57). Table 1 shows the percentages of
Finnish, Italian, and Swedish children breastfed at the ages of 6, 9,
TABLE 1 | Amounts of ingested gluten-containing cereal proteins (g per protein per kg body weight per day) and percentage of breastfeeding of healthy Finnish
(Tampere), Swedish (Gothenburg) and Italian (Naples) infants at 6, 9, and 12 months of age in 1990 at the time of the Swedish epidemic [adapted from Ascher et al. (57)
and Mäki et al. (62)].
n Wheat Rye Barley Oats
Mean SD Mean SD Mean SD Mean SD Breast-feeding
%
6 months
Tampere 73 0.06a 0.06 0.02 0.03 0.01 0.02 0.20 0.23 71
Naples 50 0.44a 0.24 10
9 months
Tampere 60 0.14a 0.09 0.08 0.10 0.03a 0.04 0.25a 0.17 47
Gothenburg 20 0.48a 0.21 0.04 0.05 0.01a 0.01 0.16a 0.14 20
Naples 58 0.6a 0.23 (1 child)
12 months
Tampere 47 0.20a 0.13 0.12 0.12 0.03 0.03 0.23 0.15 17
Gothenburg 13 0.42a 0.13 0.09 0.05 0.02 0.02 0.20 0.19 0
Naples 58 0.60a 0.25 0
aSignificant difference between countries.
In Naples no rye, barley, or oats was consumed.
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and 12 months during a time in which the diagnoses of children
under two displayed values of 7, 40, and 74%, respectively (57,
62). At the same time, in the UK and Ireland, it was observed
that breastfed babies presented with CD later than their bottle-
fed counterparts (22, 24). In 2002, Ivarsson et al. revealed the
protective effect of breastfeeding against CD (66).
As the research has suggested, breastfeeding may prevent
the development of CD. Thus, Akobeng et al. conducted a
systematic review and meta-analysis of certain observational
studies published between 1966 and 2004 (67). The meta-analysis
showed that the risk of CD was significantly reduced in infants
who were breastfed at the time of gluten introduction (pooled
odds ratio of 0.48, 95% CI 0.40–0.59) compared with infants
who were not breastfed during this period. A systematic review
from 2012 provided a similar picture, with the study concluding
that certain studies indicate a protective effect of breastfeeding,
while others do not. The meta-analysis reported a lower risk
of CD in breastfed infants, further stating, however, that it was
unclear whether those breastfed received permanent protection
from CD (68).
In 2016, a position paper by the European Society for Pediatric
Gastroenterology, Hepatology, andNutrition (ESPGHAN) stated
that breastfeeding has not been shown to reduce the risk of
CD in children (69). Indeed, new evidence on breastfeeding
not to be protective against CD has emerged from prospective
randomized clinical trials (70–72). However, the evaluated
studies were not often designed to directly address the effect of
breastfeeding on CD. At the time of the changing pattern in CD
presentation, prolonged breastfeeding in Finland was associated
with a postponed diagnosis of CD but not with its prevention
altogether (23). This effect was also observed in Ireland and the
UK (22, 24) at the same time, with breastfed infants diagnosed
with CD later than their bottle-fed counterparts despite their
similar ages at gluten introduction (24). These early reports
indicate that breastfeeding could still have contributed to the
changing epidemiology of CD (19–24).
Age at Gluten Introduction
In our study of the changing pattern observed in childhood CD
presentation (Figure 1), no correlation between age at diagnosis
and time of gluten introduction was found (23). Meijer et al.
presented recent studies as evidence of the effect of gluten
introduction timing and the associated risk of CD in young
children (73), concluding that it did not influence the risk
of CD, as also suggested by the results of large prospective
studies. Furthermore, the position paper by ESPGHAN in 2016
recommended (a) to not introduce gluten while the infant is
being breastfed as a means of reducing the risk of developing CD
(i.e., decreasing the incidence rate of CD); (b) gluten introduction
at age 4–6 months, compared to gluten introduction at age >6
months, does not reduce the cumulative incidence rate of CD in
children; (c) for children at a high risk of CD, gluten introduction
at 6 months of age compared to 12 months of age does not
reduce the cumulative incidence rate of CD but instead leads
to earlier manifestations; (d) it remains unclear whether gluten
introduction at age<3–4months compared with 4–6months has
an effect on the risk of developing CD; and (e) it remains unclear
whether gluten introduction at age <3–4 months compared to
gluten introduction at age >6 months has an effect on the risk of
developing CD (69).
Even if the current available evidence suggests that age at
gluten introduction is not associated with the changing CD
epidemiology, this review suggests that it could still have played
an important role at the time when chronic diarrhea and failure
to thrive disappeared as presenting clinical features of the disease
(19–22, 24). It should be noted that in the 1960s and earlier,
gluten was introduced to infants at a very early age. From 1960
to 1965 in Ireland, the mean age at gluten introduction for 130
newly diagnosed children was 2.3 months, while, from 1976
to 1981, it was 4.2 months (22). Moreover, in the UK before
1975, the median age at gluten introduction for diagnosed CD
patients was 2 months, while, after 1975, it increased to 4 months
(24). These changes in infant feeding patterns coincided with the
observed change in CD epidemiology.
Amount of Gluten and Quality of Cereals
The amount and type of cereals an infant ingests may play an
important role in the changing epidemiologic makeup of CD.
Since major differences in the incidence rate and presentation
of CD in Finland and Sweden were observed, a joint study was
conducted to explore potential causes of the phenomena (57).
The results from late 1980s showed that the Gothenburg region
of Sweden reported 30 times more infants diagnosed with CD
before the age of two than Tampere, Finland. At this time in
Finland, cereals were implemented gradually into infant diets
from the age of 5 months onward, with parents having a choice
between different types of gluten-containing cereals (i.e., wheat,
rye, barley, oat) or non-gluten-containing cereals (i.e., rice) in
the form of gruels or porridge. On the contrary, in Sweden since
1982, there has been a rapid introduction of gluten at the age
of 6 months. Table 1 shows the results of a prospective study
of dietary intake of gluten-containing cereals in two neighboring
countries exhibiting highly significant differences in the amount
of gluten ingested and in quality of cereals (57, 62). The Swedish
infants at the age of 9 months ingested three times and at the
age of 1 year twice the amount of wheat protein compared to
their Finnish counterparts (Table 1). The same evaluation was
at the same time conducted in Italy in the Naples region. In
Italy, weaning food was completely wheat-based. When wheat,
rye, barley, and oat proteins are counted at once, the figures of
ingested gluten of the Nordic countries converged with those of
Italy. The gluten amount ingested during infancy also correspond
to the country differences in CD incidence and prevalence at that
time (23, 40, 41, 57).
Here it should be noted that “gluten” (i.e., avenin) in oats is
not CD-inducing (74–76). Therefore, another important aspect
to consider why in the late 1980s Sweden experienced 30 times
more infants diagnosed with CD before the age of 2 than Finland,
is the amount of oats ingested by the infants: at the age of 9
months, Finnish infants ingested significantly more oat protein
than Swedish infants (Table 1).
Low wheat intake has been thought to cause the low incidence
rate of CD in the countries of Denmark (77) and Estonia (78).
When comparing the prevalence of CD in Denmark vs. Sweden
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in 1987, it was estimated that, for infants at 8 months of age, the
Swedish diet contained 40 times more gliadin than the Danish
diet, while, at 12months of age, it contained four timesmore. The
weaning food in Denmark was based on rye not wheat (77). Rye
gluten, i.e., secalin could actually be clearly less disease-inducing
than wheat gluten, i.e., gliadin.
More recently, Cresco-Escobar et al. reported that gluten
consumption patterns and the amount of gluten consumed
between the ages of 11–36 do not influence CD development
in children at a genetic risk for the disease (79). Furthermore, a
new study from the US was able to link gluten intake volume in
1-year-olds with the future onset of CD (80).
One further potential environmental factor in influencing
the presentation of CD might be the changes in the gluten-
rich cereal varieties themselves because of wheat breeding. New
hybridization techniques have been used to produce new strains
of modern wheat where celiac-triggering gluten proteins are
expressed to higher levels. These new strain do express even new
gluten proteins on which no animal or human safety testing was
conducted (81, 82).
Cow’s Milk as a Contributing Factor to CD
The present review regarded also older publications from
the time when changing clinical features were observed and
infants were fed unmodified cow’s milk. Important modern
epidemiology literature using systemic reviews and meta-
analyses has not discussed these studies. The third important
contributing factor to changing CD epidemiology in infancy, in
addition to the introduction of breast milk and gluten, might in
fact be the use of cow’s milk.
During the 1960s, young children from the Tampere region
diagnosed with CD all received homemade, diluted, cooked,
“half ”- and “two-third”-cow’s milk (23, 62, 83). The shift from
using diluted cooked cow’s milk to humanized, i.e., more
breast milk resembling cow’s milk-based infant formulas took
place in Finland during the year 1972. This, together with
the decrease in the amount of ingested gluten as a result of
prolonged breastfeeding, could have significantly contributed to
the disappearance of the symptomatic forms of CD in young
children. In the UK, bottle-fed infants presented earlier with CD
when compared to breast-fed infants (24). This was true both
prior to 1975 when gluten was introduced at a median age of
2 months as well as after 1975 when gluten was introduced at
a median of 4 months. Before the mid 1970s, most artificially-
fed Irish infants received formulas containing unmodified cow’s
milk, with the total protein content and osmolarity of such
formulas both reduced at the same time as the decreasing
incidence rate of CD was observed. Humanized infant formulas
were implemented from 1978 onwards both in the UK and
Ireland (22).
Kuitunen et al. reported that malabsorption syndrome caused
by cow’s milk protein intolerance in patients from 1962 to
1971 was a clear-cut clinical entity; gluten was not the causing
factor of the disease (84). Moreover, small-intestinal biopsies
obtained from these infants showed that the jejunal mucosa
was injured, the patients displayed villous atrophy with crypt
hyperplasia that was undistinguishable from that of untreated
CD. The development of a so-called flat lesion was observed in
approximately half of the patients (84–86). During the 1960’s,
a high incidence rate of cow’s milk intolerance at infancy was
found in diagnosed CD. Kuitunen et al. suggested that cow’s milk
intolerance may “pave the way” to CD (85).
A recent study by Hyytinen et al. did not find evidence that
weaning off a diet of extensively hydrolyzed formula (compared
to the implementation of cow’s milk-based formula) would
decrease the risk of CD later in life (87). It is not clear whether
the breastfeeding and gluten introduction timelines presented
in this study (87) are comparable with those from the previous,
aforementioned studies (22–24). Furthermore, it is also currently
unclear whether the cow’s milk formula used by Hyytinen et al.
(87) (80% intact milk protein, Enfamil; Mead Johnson, Chicago,
IL, USA, and 20% hydrolyzedmilk protein)mimicked the protein
content and osmolarity of the homemade, cooked, diluted cow’s
milk used during the 1960s and early 1970s.
National Recommendations Causing
Celiac Disease (“The Swedish Epidemic”)
Celiac disease (CD) is an example of when a national
recommendation can modify a disease’s epidemiology. The trend
in Europe of disappearing infant CD and the shift of age at
diagnosis (19–24, 38) was not observed to be the same among
all countries, with Sweden being an exception (40, 57, 77). In
2000, Ivarsson et al. investigated the countrywide epidemic of
chronic malabsorptive syndrome occurring during infancy for a
10-year period from 1985 to 1995. The annual incidence rate of
CD in children <2 years of age was found to increase four-fold
during the epidemic in Sweden (40). Before the epidemic in 1983,
recommendations for age at gluten introduction changed from 4
to 6 months of age, and as previously discussed, there was a rapid
introduction of a high amount of gluten at the age of 6 months,
inducing CD. In 1983, due to national recommendations, the
amount of gluten in industrially produced weaning food in
Sweden had been doubled on average. The curve presented
by Ivarsson et al. for the wheat-rye-barley index based on
the estimated average daily consumption of gluten-containing
follow-on formulas followed the pattern of the epidemic in
this country (40). However, it was observed that oats were not
included in this cereal index curve but the estimated average
daily consumption of oats was given (40). So, the curve for oats
consumption was drawn exhibiting a U-shape, suggesting that
the less oats ingested, the higher the incidence rate of infantile
CD. The epidemic disappeared when wheat-based gluten content
in the follow-on formulas was reduced (40). Table 1 shows the
differences in cereal consumption patterns for the ages of 9 and
12 months in Sweden and Finland.
An important message from the Swedish CD epidemic is that
authority directives can completely change the overall makeup of
a disease over a short time period.
Infections and the Microbiome
Infantile gastroenteritis and other infections could be potential
environmental factors functioning at the small intestine mucosal
level and potentially leading to overt CD in children exhibiting
normal mucosa (62). Furthermore, the rotavirus has been
implicated as potentially triggering the onset of CD (88). A
large cohort study of children with HLA risk alleles for CD
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found that frequent rotavirus infections (and not clinically
symptomatic gastroenteritis) predicted a higher risk of CD
autoimmunity (89). Furthermore, rotavirus infection increased
CD autoimmunity, while vaccination seemed to reduce this risk
(90). In fact, rotavirus infection may cause the manifestation of
a small intestinal crypt hyperplastic injury with villous atrophy
undistinguishable from the effects of gluten in CD, which
was observed in both an experimental animal model and a
child with rotavirus infection (91, 92). Recently, an experiment
performed by Bouziat et al. on a human reassortant reovirus
infection in mice was shown to trigger inflammatory responses
to dietary antigens (93). In their study also CD patients tended
to present with higher incidence rates of anti-reovirus (but not
the rotavirus) antibody levels compared to the controls. Bouziat
et al. further concluded that their study in humans supported the
role of the reovirus, a seemingly innocuous virus, in triggering
the development of CD (93). Recently, an association between
enterovirus infection and later CD presentation was also reported
(94). Furthermore, there has been evidence that, in general, any
type of infection could be associated with an increased risk of
CD (95, 96).
Since the rotavirus has been implicated as potentially
triggering the onset of CD, live oral rotavirus vaccines could
conceivably have a similar effect. However, a Finnish study in
2017 suggested that rotavirus vaccination did not increase the risk
of CD in rotavirus-vaccinated children compared to those not
vaccinated (97). In fact, rotavirus vaccination could even decrease
the occurrence of CD in children and adolescents (98).
Tye-Din et al. discussed the complex role of microbiota in CD
development (99). They found that factors such as environment,
diet, and antibiotics can change the CD microbiome and
its interactions with intestinal epithelial cells. The authors
concluded that larger trials are warranted when microbiota
are studied in at-risk individuals and must be followed-up
with for a certain period of time to further understand gene-
microbiome interactions in CD development (99). Recently,
an observational, nationwide, register-based cohort study of
children was performed in Norway and Denmark from 1995 to
2012 to elucidate the results of systemic antibiotic use in regard
to CD (100), which indicated that childhood exposure to systemic
antibiotics could be a risk factor of CD.
When examining the environment in which the changing
pattern of CD occurred in children (Figure 1), robust
epidemiological data supports the influence of gastroenteritis,
especially of the bacterial variety rather than the rotavirus-
induced disease (101). Figure 3 presents all cases of childhood
diarrhea in the country reported to the National Board of Health
in Helsinki, Finland over two 10-year periods. Diarrhea cases
occurring during the summer, which produced large infant
mortality rates, were seen to completely disappear during
the 1970s in Finland. Moreover, the shape of the curve was
now typical of the rotavirus infection, with the rotavirus also
associated with half of all hospitalization cases from the years
1977 to 1978 (102). Additionally, enteropathogenic bacteria
accounted for only 10% of all hospitalized cases. These were
Yersinia, Campylobacter, certain strains of Salmonella, a few
enteropathogenic Escherichia coli serotypes (EPEC), and zero
Shigellas (102, 103). It should be noted that classical cases of CD
FIGURE 3 | Seasonal distribution of all reported cases of diarrhea in Finland
during two 10-year periods [adapted from Mäki et al. (101)].
in young infants disappeared throughout Finland, even though
the rotavirus was seen to greatly induce diarrhea and accounted
for 50% of all hospitalization cases at that time (103). EPEC was
seen to be most abundant during the summer months of the
1950s and was detected in 24% of all diarrhea cases in children
ages 0–3 and in 28% of diarrhea cases for ages 3–6 months (101).
Fewer “summer diarrhea” cases were reported during the 1960s;
however, they were still quite prevalent and only completed to
disappeared during the 1970s (101). Furthermore, the observed
rate of hypertonic and hypotonic dehydration was only 3%
in 1978, with 97% of all hospitalized children with diarrhea
displaying isotonic dehydration (at the time when CD in infants
had already disappeared) (101).
There are still some countries reporting the classical
forms of CD in young children. For example, in Romania,
enteropathogenic bacteria, EPEC, and infestations like giardia are
all quite prevalent while very rare in Finland. Indeed, Romania
is still currently experiencing several celiac crises, with eight
new childhood cases occurring within just 1 year in Bucharest.
On the other hand, general autoimmunity and pediatric chronic
inflammatory bowel disease occur infrequently in Romania when
compared to several other countries.
Autoimmunity and the Hygiene Theory
The increased prevalence of autoimmune diseases over time in
industrialized countries is thought to be caused by a reduction
in the incidence rate of infectious diseases, which is called the
hygiene hypothesis. Early exposure to certain microorganisms
during infancy directs and educates the human immune system.
The frequency of infections directly contributes to an increase
in autoimmune diseases, while infectious agents suppress
autoimmune disorders (104, 105). Dysbiosis of commensal
intestinal bacteria also plays an important role in autoimmune
diseases, and the mechanisms inducing autoimmunity are a
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complex combination of various environmental factors. In one
study, intestinal microbiome development was examined in
children from ages 0–3 in Northern Europe, in which early-onset
autoimmune diseases are common, particularly in countries like
Finland, while less common in countries like Russia (106). The
study then suggested that the immunogenicity of early colonizing
symbiotic bacteria could be a potential contributing factor to
autoimmunity in humans.
The fact that diarrheal diseases and infections trigger CD and
that antibiotic treatment at an early age increases the risk of the
disease have already been mentioned in this paper. At the same
time, the hygiene theory argues that the presence of microbiota
and infections at an early age are essential in suppressing
subsequent autoimmunity. CD is, in fact, an autoimmune disease
in which, in contrast to other autoimmune diseases, the driving
force behind the disease is known: the daily ingestion of gluten
(107–110). Furthermore, a shift in the pattern of CD presentation
toward older age at diagnosis has been evident (23), with the
disease altogether not prevalent in adults prior to the 1970s.
Changes in the clinical features of the disease in adults were
examined in a study conducted in Scotland from 1960 to 79 (111)
and later in Finland, with an increased awareness and use of
autoantibody case-finding tools (8) associating with CD’s high
prevalence in adults (112). In certain population-representative
screening studies, an increased prevalence of CD autoimmunity
was noted by age: 1.5% in children (113), 2.0% in adults (114),
and 2.7 % in the elderly (115). It was further shown that the
prevalence of CD (i.e., autoimmunity) at the population level
is increasing over time, doubling within the last two decades in
Finland (114). Other studies later confirming this finding were
conducted in the USA (116, 117). It has also been suggested
that, for children, there is an increasing incidence over time
(118, 119). Very recently, in fact, an increase in the prevalence in
childhood CDwas confirmed in Italy, showing a prevalence at the
population level of 0.70% in 1994 and 1.58% in 2016 (120, 121).
In Russian Karelia, the population currently appears to be
protected against autoimmune diseases. When compared to
Finland, type I diabetes in children was six times less prevalent
in Russia (122). A similar study comparing the prevalence of
CD by screening 1988 schoolchildren from Russian Karelia and
3,654 children from Finland was performed and yielded the same
result; CD was five times less frequent in Karelia. This may
be associated with a protective environment characterized by
inferior prosperity and standard of hygiene in Russian Karelia
(123). In Finland, decreased microbial exposure in childhood
seems to lead to increasing prevalence of autoimmune diseases
and CD. In Russian Karelia, understanding could be enhanced in
regard to the environmental factors involved in CD protection, as
long as the sharp environmental gradient across the border is still
existing. Vatanen et al. (106) have already initiated such studies
on the microbiome.
INCIDENCE RATES AND PREVALENCE
In the 1980s in Tampere, Finland, an increase in the number
of childhood CD cases diagnosed annually were reported at the
same time as a decrease in incidence rates in both the UK and
Ireland were also reported (19–22). As shown in Figure 1, this
was due to a greater awareness of the mild form of the disease
and atypical cases among school-age children. Additionally, by
the late 1970s, the use of the modern tissue autoantibody test
of the IgA class began to be used in case-finding, i.e., the R1
reticulin antibody test, later called the endomysial (EMA), and
the tissue transglutaminase antibody (TG2-ab) test (12, 15).
In 1990, it was reported that a decrease in the incidence rate
of CD for children under 2 years of age occurs but that at
school age increased significantly (83). This is displayed in
Table 2 where all children born in a strict geographical area
during 1964–1988 were divided in 5-year birth cohorts and
followed up to the age of 16. Table 2 shows the numbers of
CD patients diagnosed by the healthcare professional and the
5-year birth cohort incidence rate per year for different ages
and the total prevalence during childhood up the age of 16.
In the later birth cohort groups infant CD disappeared but the
total prevalence of CD appeared stable during childhood (83).
In terms of contracting the disease under 2 years of age, the
risk for those born from 1964 to 1968 was 5.7-fold compared
to those born from 1979 to 1983 or 1984 to 1988. Today,
the children from the different birth cohorts are 30–55 years-
old, and the current prevalence of CD among the same group
TABLE 2 | Birth cohort incidence rate of 1,000 live births per year at different ages and total prevalence of celiac disease during 5-year periods from 1964 to 1988
[adapted from reference Mäki and Holm (83)].
Year of birth (No. of
live births)
Age of diagnosis (years) Total prevalence
(95% confidence
interval)<2 2–5 6–10 11–16
n Incidence pa n Incidence pa n Incidence pa n Incidence pa
1964–1968 (29 056) 13 0.22 3 0.03 2 0.01 11 0.06 1.00 [0.64–1.36]
1969–1973 (24 646) 7 0.14 NS 3 0.03 NS 3 0.02 NS 8 0.05 NS 0.85 [0.49–1.22]
1974–1983 (25 962) 4 0.08 NS 3 0.03 NS 7 0.05 <0.10 10 (0.06)b NS (0.92)b [0.55–1.29]
1979–1983 (25 466) 2 0.04 <0.01 4 0.04 NS 9 (0.07)b <0.025
1984–1988 (25 500) 2 (0.04)b <0.01 4 (0.04)b NS
aSignificance as compared to the incidence for birth cohort 1964–1968.
bNot final incidence and prevalence but at least minimum value.
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TABLE 3 | Changes in incidence rates of childhood celiac disease over time.
Author (reference
number)
Study period Age groups (years) Incidence per 1,000
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could be evaluated, which is probably not the 0.1% shown in
Table 2 but rather 10–20 times higher, evidenced by population-
based screening studies and the established pattern of increasing
prevalence over time (113, 114). In addition, these birth cohorts,
when followed-up with for 30–50 years, could further provide
insights into this increase in prevalence over time. Thus, it is
hypothesized that, based on the prevalence of the increase in
population-representative adult materials (114), the two 5-year
birth cohorts from the years 1964 to 1968 and 1969 to 1973
present lower total CD prevalence than the three 5-year birth
cohorts from the years 1974 to 1988. However, it must be noted
once more that, today, new seroconversions can still occur at
older ages (115).
The lowest incidence rate per 1,000 live births (0.04) was
reported in Estonia during the mid 1970s (78). In 2012, based
on a nationwide study of childhood CD, Ress et al. showed
a more than 30-fold increase in the incidence rate over a 35-
year period in Estonia (53) (Table 3). This was due to an
awareness of existing even clinically silent CD and case-finding
produced through an autoantibody screening. Denmark and
The Netherlands similarly reported very low incidence rates
that increased over the years (Table 3), which are speculated to
potentially be due to changes in the environment (124, 125).
Table 3 also shows the selected incidence rates of CD of several
different countries per 1,000 live births every year or per 100,000
people every year.
Table 4 presents childhood CD prevalence figures, including
both the biopsy-supported and serologically detected (celiac
autoimmunity) diagnosis types, from various parts of the world.
The overall prevalence of CD was observed to be∼1%. However,
population-representative screening further revealed that several
countries, such as Argentina (135), Finland (113), Hungary (142,
143), Italy (121, 147–149), Spain (154), Sweden (157–160), and
Turkey (163), were approaching a childhood prevalence of 1%
or more. Meanwhile, countries exhibiting low CD prevalence
included, among others, Estonia (138, 139), and Russia (123)
(Table 4). The quite low prevalence rate observed for Denmark,
even after its increase over the years (128), indicates that CD
awareness is low among healthcare professionals and that serum
autoantibody case-finding screening in the primary care field
is not often performed. Furthermore, a questionnaire-based
case-finding was conducted in Denmark in which children
exhibiting celiac-related symptoms were invited to participate
in a serological test. This evaluation showed that 14 out of
9,967 school-aged children suffer from CD in Denmark. For
the same population, an additional 13 patients also had a
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TABLE 4 | Prevalence of childhood celiac disease and celiac autoimmunity in different countries.
Author (reference
number)







Chin et al. (134) 0.6
Argentina
Mora et al. (135) 2008–2009 1.30
Brasil
Pratesi et al. (136) 2003 0.54 0.27–0.57
Egypt
Abu-Zekry et al. (137) 2001–2004 0.53 0.17–0.89
Denmark
Dydensborg et al. (128) 1996–1999 0.04
2000–2010 0.08
Estonia
Ress et al. (138) 2004–2005 0.34 0.09–0.88
Lillemae et al. (139) 1998–1999 0.34 0.09–0.88 0.43
Finland
Mäki et al. (113) 1994 1 0.68–1.33 1.50
Germany






Korponay-Szabo et al. (142) 1.20
Korponay-Szabo et al. (143) 2005 1.38 0.94–1.82
India
Makharia et al. (144) 2008–2009 1.04 0.85–1.25 1.44
Iran
Farahmand et al. (145) 2006–2008 0.5
Dehghani et al. (146) 0.60 2.00
Italy
Catassi et al. (120) 1994 0.70 1.5
Tomassini et al. (147) 1999–2000 0.94
Mustalahti et al. (148) 1997–2000 1.1
Bonamico et al. (149) 2007 1.16
Gatti et al. (121) 2016 1.58
Netherlands
Csizmadia et al. (150) 1987–1997 0.5
Norway
Størdal et al. (151) 2008–2011 0.38 0.37–0.39
Russia
Kondrashova et al. (123) 1997–2001 0.2
Saudi Arabia
Al–Hussaini et al. (152) 2014–2016 1.5
Spain
Almazán et al. (153) 2009–2012 3
Cilleruelo et al. (154) 2004–2005 1.16 0.54–1.78
Marine et al. (155) 2004–2007 0.49
2006–2007 0.49
Castaño et al. (156) 1998–1999 0.84
after 2.5 years 1.4
Sweden
Carlsson et al. (157) 1995 2
Carlsson et al. (158) 2000 1 0.7
Myleus et al. (159) 2005–2006 2.9 2.5–3.3
(Continued)
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TABLE 4 | Continued
Author (reference
number)






Ivarsson et al. (160) 2005–2006 2.90
2009–2010 2.20
Tunisia
Hariz et al. (161) 2003–2005 0.45 0.64
Hariz et al. (162) 2011 0.24
Turkey
Demirceken et al. (163) 0.9
Dalgic et al. (164) 2006–2008 0.47 0.38–0.57 1.74
United Kindom
Mustalahti et al. (148) 2000 0.9
USA
Fasano et al. (165) 1996–2001 0.31 0.09–0.80
previous diagnosis of CD; thus, the prevalence rate increased
to 0.27% (166). However, this value is still quite low for a
country in which screened type 1 diabetes patients are known
to often conduct CD as well (10.4%) (167). The high prevalence
rate (3%) of CD in Swedish children also can be commented
upon (159). In that study in Sweden, the children were born
during the epidemic described, experienced high volumes of
gluten in their weaning food, and their screening took place
when they were 12 years of age. It can be speculated that
their high gluten intake at a young age contributed to the 3%
prevalence rate. On the other hand, it should also be noted
that in the Swedish study the diagnostic criteria for CD were
somewhat unconventional, also including symptomatic patients
with only increased intraepithelial lymphocyte counts shown in
their biopsy results (Marsh class 1). Patients with no symptoms
but exhibiting Marsh 1 lesions were again not considered to
have CD. Overall, when comparing the incidence and prevalence
studies from different countries in which a biopsy was the
primary detection method, the poor celiac center pathologist
interobserver reproducibility of the small intestinal mucosal
injury, i.e., the Marsh classes, must be kept in mind. A normal
mucosa graded as Marsh 0 may be Marsh 3 c and vice versa
(168, 169).
CONCLUSIONS
The observed changes in childhood CD presentation and
epidemiology have been remarkable during the past 50 years,
with overall clinical childhood CD presenting as a malabsorption
syndrome transforming into a milder form, resulting in an
upward shift of age at diagnosis. The incidence rates and
prevalence of childhood CD have been constantly increasing due
to case-finding screening strategy. The most important factor
in the increasing rates of CD seemed to be an awareness of
healthcare professionals of this changing pattern, the existence of
which is quite evidence-based. This change took place at different
times in different countries, resulting in several global differences.
Today, the best case-finding biomarkers for the screening of
undiagnosed CD are gluten-dependent serum autoantibody tests,
and it is recommended that these tools be used in the primary
care field. There is also evidence of an increase in CD prevalence
in children over time that is similar to that observed in adults. The
main question involved in this change in prevalence asks for the
reasons behind these observed clinical changes. This study thus
discusses changing environmental factors, such as breastfeeding,
gluten, and cow’s milk ingestion, and infections as causes for
the observed changes. To prospectively readdress these questions
using modern epidemiological tools, it is suggested that studies
be conducted in countries in which the classic presentation of
CD in young children, including diarrhea and malabsorption
syndrome, still exists. Overall, an oral tolerance toward gluten
could still exist in certain settings, and the environmental
factors involved in infantile CD and increasing prevalence of
autoimmunity at older ages could still be further investigated by
future studies.
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